Insulet Corp. (PODD)
289.71
+0.98
(+0.34%)
USD |
NASDAQ |
Dec 17, 14:04
Insulet Research and Development Expense (Annual): 219.60M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Baxter International, Inc. | 510.00M |
| Boston Scientific Corp. | 1.615B |
| ResMed, Inc. | 331.28M |
| Tandem Diabetes Care, Inc. | 184.17M |
| Phibro Animal Health Corp. | 23.73M |